About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Epilepsy Clinical Trials in Philadelphia | 134 Studies

Clinical Trials EpilepsyPhiladelphia

Epilepsy Clinical Trials in Philadelphia

Find 134 clinical trials for epilepsy near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Epilepsy trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 134 trials

CompletedA Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset SeizuresThe study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3…NCT00465517·Birmingham, Alabama and 26 others Active not recruitingA Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyThe purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.NCT06132893·Phoenix, Arizona and 103 others

Epilepsy Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

RecruitingStudy Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures.NCT07563881·Birmingham, Alabama and 23 others

CompletedEslicarbazepine Acetate Monotherapy Long Term StudyThis is a long term, open-label, safety extension study in subjects with partial onset seizures.NCT00910247·Northport, Alabama and 121 others

TerminatedA Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant EpilepsyThe purpose of the study is to evaluate the efficacy, safety and tolerability of the 3 selected dose regimens of padsevonil (PSL) administered concomitantly with up to 3…NCT03739840·Chandler, Arizona and 140 others

TerminatedStudy to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure ClustersThe purpose of this study is to examine the safety and effectiveness of USL261 for the outpatient treatment of seizure clusters.NCT01390220·Phoenix, Arizona and 89 others

CompletedA Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut SyndromeThis is a two-part, multicenter, double-blind, parallel-group, placebo controlled study to evaluate the effect of ZX008 when used as adjunctive therapy for the treatment of…NCT03355209·Tucson, Arizona and 71 others

CompletedDetermine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial SeizuresThe purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsyNCT00522275·Birmingham, Alabama and 59 others

Enrolling by invitationLong-term Safety and Tolerability of BHV-7000A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsyNCT06443463·Birmingham, Alabama and 282 others

CompletedRNS® System LTT StudyThe RNS® System LTT study is designed to assess the ongoing safety and to evaluate the long-term efficacy of the RNS® System as an adjunctive therapy in reducing the frequency of…NCT00572195·Phoenix, Arizona and 32 others

CompletedOpen-label Extension to Protocol 1042-0600To allow open-label extension to patients who have completed Protocol 1042-0600.NCT00512317·Birmingham, Alabama and 24 others

CompletedA Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in EpilepsyThe purpose of this study is to evaluate the efficacy of up to 3 dose levels of adjunctive JNJ-40411813 compared to placebo based on the time to baseline monthly seizure count in…NCT04836559·Tucson, Arizona and 68 others

CompletedCX-8998 for Absence SeizuresThis is a Phase 2a, open-label study consisting of a screening period of up to 4 weeks and a 4-dose-titration treatment period to a dose of up to 10 mg twice daily (BID) of…NCT03406702·Little Rock, Arkansas and 6 others

TerminatedCannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence SeizuresThe primary purpose of this study is to assess the efficacy of Cannabidiol Oral Solution in the treatment of pediatric participants with treatment-resistant childhood absence…NCT03336242·Miami, Florida and 10 others

TerminatedAn Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset SeizuresThe purpose of this study is to assess the long-term safety and tolerability of CVL-865 as adjunctive therapy in participants with focal onset seizures.NCT04686786·Little Rock, Arkansas and 55 others

CompletedBrivaracetam Efficacy and Safety Study in Subjects With Partial Onset SeizuresThis study will evaluate the efficacy and safety of brivaracetam at doses of 100 and 200mg/day compared to placebo as adjunctive treatment in adult focal epilepsy subjects with…NCT01261325·Phoenix, Arizona and 206 others

CompletedPediatric Epilepsy StudyThis study will evaluate the safety and effectiveness of oxcarbazepine (Trileptal) as monotherapy in the treatment of partial seizures in pediatric patients 1 month to 3 years of…NCT00050947·Birmingham, Alabama and 29 others

CompletedA Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset SeizuresA study of a drug to be used in addition with another drug to treat adults with Uncontrolled Partial-onset SeizuresNCT03116828·Mobile, Alabama and 54 others

CompletedPreventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis ComplexStudy design is a Phase IIb prospective multi-center, randomized, placebo-controlled, double-blind clinical trial.NCT02849457·Birmingham, Alabama and 12 others

TerminatedAn Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEETo assess the long-term safety and tolerability of XEN496 in pediatric subjects with KCNQ2 developmental and epileptic encephalopathy (KCNQ2-DEE) who had participated in the…NCT04912856·Philadelphia, Pennsylvania and 3 others

PreviousPage 3 of 7Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia